Alexion Pharm Inc
(ALXN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 2,404,300 | 1,515,300 | 1,047,700 | 587,900 | 77,600 |
| Depreciation Amortization | 376,800 | 286,200 | 193,700 | 97,200 | 418,800 |
| Income taxes - deferred | -455,400 | -136,100 | -40,800 | -81,100 | 32,900 |
| Accounts receivable | -319,200 | -199,100 | -196,400 | -95,300 | -208,800 |
| Other Working Capital | -279,700 | -140,100 | -323,600 | -173,300 | -454,700 |
| Other Operating Activity | 358,100 | 241,600 | 287,700 | 94,500 | 560,200 |
| Operating Cash Flow | $2,084,900 | $1,567,800 | $968,300 | $429,900 | $426,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 180,500 | 157,800 | 96,300 | 90,500 | 680,700 |
| PPE Investments | -154,700 | -124,700 | -82,800 | -36,000 | -213,000 |
| Purchase Of Investment | N/A | -63,700 | -43,800 | -43,800 | N/A |
| Purchase Sale Intangibles | -16,000 | -16,000 | -8,000 | -8,000 | N/A |
| Other Investing Activity | -16,100 | -16,000 | -7,800 | -7,800 | 2,800 |
| Investing Cash Flow | $9,700 | $-46,600 | $-38,100 | $2,900 | $470,500 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 250,000 |
| Debt Issued | N/A | N/A | -32,700 | N/A | N/A |
| Debt Repayment | -98,000 | -65,400 | N/A | N/A | -293,800 |
| Common Stock Issued | N/A | 23,200 | 20,500 | 10,200 | N/A |
| Common Stock Repurchased | -416,000 | -383,500 | -48,900 | -11,300 | -85,000 |
| Other Financing Activity | -225,100 | -253,700 | -252,400 | -251,300 | 26,400 |
| Financing Cash Flow | $-739,100 | $-679,400 | $-313,500 | $-252,400 | $-102,400 |
| Exchange Rate Effect | 800 | -6,100 | 700 | -1,400 | -11,200 |
| Beginning Cash Position | 1,367,300 | 1,367,400 | 1,367,300 | 1,367,300 | 584,400 |
| End Cash Position | 2,723,600 | 2,203,100 | 1,984,700 | 1,546,300 | 1,367,300 |
| Net Cash Flow | $1,356,300 | $835,700 | $617,400 | $179,000 | $782,900 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,084,900 | 1,567,800 | 968,300 | 429,900 | 426,000 |
| Capital Expenditure | -154,700 | -124,700 | -82,800 | -36,000 | -213,000 |
| Free Cash Flow | 1,930,200 | 1,443,100 | 885,500 | 393,900 | 213,000 |